RECOVER-TLC seeks input on planned study of possible Long COVID treatment
Announcement
February 23, 2026 1 min read
Members of the public will have two weeks to provide feedback on a clinical trial testing the safety and effectiveness of a medical procedure that could help people experiencing a range of Long COVID symptoms.
RECOVER-Treating Long COVID (RECOVER-TLC) invites patients, caregivers, advocates, healthcare providers, and researchers to provide feedback on its upcoming stellate ganglion nerve block (SGB) clinical trial.
RECOVER-TLC wants to collect feedback on this planned clinical trial in the form of public comments on the draft SGB Protocol Synopsis. This draft protocol synopsis (brief summary) contains information about the questions the study will investigate, how researchers will look for answers, and who can join the study. The draft SGB Protocol Synopsis and comment submission form will be made available on the RECOVER-TLC Collaborator Portal on February 23 and will remain accessible for 2 weeks, closing on March 8 at 11:59 pm ET.
RECOVER-TLC seeks input on planned study of possible Long COVID treatment [stellate ganglion nerve block (SGB)]
recovercovid.org/news/recover...
#LongCovid #SGB